SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-092970
Filing Date
2022-08-19
Accepted
2022-08-19 16:13:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2223785d1_s3.htm S-3 151425
2 EXHIBIT 5.1 tm2223785d1_ex5-1.htm EX-5.1 28076
3 EXHIBIT 23.1 tm2223785d1_ex23-1.htm EX-23.1 2535
4 EX-FILING FEES tm2223785d1_ex-filingfees.htm EX-FILING FEES 16205
5 GRAPHIC tm2223785d1_s3-img002.jpg GRAPHIC 3281
6 GRAPHIC tm2223785d1_s3-img003.jpg GRAPHIC 3321
7 GRAPHIC tm2223785d1_ex5-1img001.jpg GRAPHIC 12390
8 GRAPHIC tm2223785d1_ex5-1img002.jpg GRAPHIC 2964
  Complete submission text file 0001104659-22-092970.txt   230268
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266984 | Film No.: 221180941
SIC: 2834 Pharmaceutical Preparations